You are here

You are here

AKU wins Rs14.5mn grant to develop new, targeted stem cell treatments for blood cancer

21 January 2021

The Aga Khan University (AKU)’s Centre for Regenerative Medicine and Stem Cell Research (CRM) has won a Rs14.5 million grant to develop new, targeted therapies for a common form of blood cancer in adults. AKU researchers are looking to develop a more effective treatment by engineering stem cells to deliver a protein with therapeutic properties. The grant was awarded by the Higher Education Commission of Pakistan’s flagship National Research Programme for Universities that seeks to support high-level and promising scientific research projects that demonstrate strategic relevance and impact to local industry and society.